Appendix Table 1.
Antiretroviral Class | Central Nervous System Penetration Effectiveness Rankinga |
|||
---|---|---|---|---|
4 | 3 | 2 | 1 | |
Nucleoside analogue reverse transcriptase inhibitors | Zidovudine | Abacavir | Didanosine | Tenofovir |
Emtricitabine | Lamivudine | Zalcitabine | ||
Stavudine | ||||
Nonnucleoside analogue reverse transcriptase inhibitors | Nevirapine | Delavirdine | Etravirine | |
Efavirenz | ||||
Protease inhibitors | Indinavir/ritonavir | Darunavir/ritonavir | Atazanavir | Nelfinavir |
Fosamprenavir/ritonavir | Atazanavir/ritonavir | Ritonavir | ||
Indinavir | Fosamprenavir | Saquinavir | ||
Lopinavir/ritonavir | Saquinavir/ritonavir | |||
Tipranavir/ritonavir | ||||
Entry/fusion inhibitors | Maraviroc | Enfuvirtide | ||
Integrase strand transfer inhibitors | Raltegravir |
a Higher rankings reflect better central nervous system penetration estimates.